Recombinant Human Phospholipase C Epsilon 1 (PLCe1)
Recombinant Human Phospholipase C Epsilon 1 (PLCe1) is a purified Prokaryotic Protein. Purity: >90% by SDS-PAGE. Host: E. coli. Endotoxin Level: <1.0EU per 1ug, by the LAL method. Species: Human (Homo sapiens) . Target Name: Phospholipase C Epsilon 1 (PLCe1) . Target Synonyms: PLCE; NPHS3; PPLC; Phosphoinositide phospholipase C-epsilon-1; Pancreas-enriched phospholipase C; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1. Accession Number: Q9P212. Gene ID: 51196. Expression Region: Met1~Gln250. Tag Info: N-terminal His and GST Tag. Theoretical MW: 58kDa. Buffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose. Storage: -20°C. Avoid repeated freeze/thaw cycles. Restrictions: For Research Use Only. Not for use in diagnostic procedures.
Product Specifications
CAS Number
9000-83-3
Short Description
Recombinant Human Phospholipase C Epsilon 1 (PLCe1) is a purified Prokaryotic Protein.
Gene ID
51196
Accession Number
Q9P212
Expression Region
Met1~Gln250
Expression System
Prokaryotic Expression
Host
E. coli
Target
Phospholipase C Epsilon 1 (PLCe1)
Conjugation
Unconjugated
Tag
N-Terminal His and GST Tag
Applications
Positive Control, Immunogen, SDS-PAGE, WB
Field of Research
Metabolic Pathway
Endotoxin
<1.0EU/ug, by the LAL method
Purity
>90% by SDS-PAGE
Activity
Not Tested
Format
Freeze-dried powder
Buffer
PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
Reconstitution
Refer to the datasheet/CoA included in the product pouch.
Molecular Weight
58kDa
Shipping Conditions
Ice packs
Storage Conditions
-20°C. Avoid repeated freeze/thaw cycles.
Target Alternative Name
Species
Human (Homo sapiens)
Protein Name
Prokaryotic Protein
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Shigella Sonnei mepA Protein (aa 20-274)
ALOX5 (ALOX5, 5-LO, 5-LOX, 5LPG, LOG5, MGC163204, 5-Lipoxygenase) (MaxLight 550)
ALOX5 (ALOX5, 5-LO, 5-LOX, 5LPG, LOG5, MGC163204, 5-Lipoxygenase) (MaxLight 550)
C6orf70 sgRNA CRISPR Lentivector (Human) (Target 2)